Correction: HALO Momentum Expected To Continue
(Thomson Reuters ONE) -
In an August 8 report on Halozyme Therapeutics (NASDAQ:HALO), the following
statement:
"With $102 million in cash ($1 per share) and no debt, management reiterating on
its conference call that it expects to become profitable in 2014, and statements
that HALO has preclinical data to address the FDA's requests for the Baxter
(NYSE:BAX) and ViroPharma (NASDAQ:VPHM) product candidates, the stock remains a
good value and could continue to trade higher."
Has been changed to:
"With $102 million in cash ($1 per share) and no debt, management reiterating on
its conference call that it expects to become profitable in 2014, and statements
that HALO may have preclinical data to address the FDA's requests for the Baxter
(NYSE:BAX) and ViroPharma (NASDAQ:VPHM) product candidates, the stock remains a
good value and could continue to trade higher."
This change is reflected on our website, here.
About PropThink
PropThink is an intelligence service that delivers long and short trading ideas
to investors in the healthcare and life sciences sectors. Our focus is on
identifying and analyzing technically-complicated companies and equities that
are grossly over or under-valued. We offer daily market coverage, weekly feature
stories, and a newsletter to investors who subscribe on PropThink.com. To learn
more visit us at http://www.propthink.com.
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: PropThink via Thomson Reuters ONE
[HUG#1633374]
Unternehmensinformation / Kurzprofil:
Datum: 10.08.2012 - 22:00 Uhr
Sprache: Deutsch
News-ID 173754
Anzahl Zeichen: 2068
contact information:
Town:
New York
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 227 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Correction: HALO Momentum Expected To Continue"
steht unter der journalistisch-redaktionellen Verantwortung von
PropThink (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
